| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3362 | 2020 |
| 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the … M Humbert, G Kovacs, MM Hoeper, R Badagliacca, RMF Berger, M Brida, ... European heart journal 43 (38), 3618-3731, 2022 | 2141* | 2022 |
| TGF-β1 and angiotensin networking in cardiac remodeling S Rosenkranz Cardiovascular research 63 (3), 423-432, 2004 | 951 | 2004 |
| Left ventricular heart failure and pulmonary hypertension S Rosenkranz, JSR Gibbs, R Wachter, T De Marco, A Vonk-Noordegraaf, ... European heart journal 37 (12), 942-954, 2016 | 684 | 2016 |
| Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model MM Hoeper, T Kramer, Z Pan, CA Eichstaedt, J Spiesshoefer, N Benjamin, ... European Respiratory Journal 50 (2), 2017 | 664 | 2017 |
| Pulmonary arterial hypertension: epidemiology and registries MD McGoon, RL Benza, P Escribano-Subias, X Jiang, DP Miller, ... Journal of the American College of Cardiology 62 (25S), D51-D59, 2013 | 658 | 2013 |
| Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study M Augustin, P Schommers, M Stecher, F Dewald, L Gieselmann, H Gruell, ... The Lancet Regional Health–Europe 6, 2021 | 657 | 2021 |
| Estrogen Modulates AT1 Receptor Gene Expression In Vitro and In Vivo G Nickenig, AT Bäumer, C Grohè, S Kahlert, K Strehlow, S Rosenkranz, ... Circulation 97 (22), 2197-2201, 1998 | 543 | 1998 |
| Pulmonary hypertension due to left heart disease JL Vachiéry, RJ Tedford, S Rosenkranz, M Palazzini, I Lang, M Guazzi, ... European respiratory journal 53 (1), 2019 | 523 | 2019 |
| Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry MM Hoeper, D Huscher, HA Ghofrani, M Delcroix, O Distler, C Schweiger, ... International journal of cardiology 168 (2), 871-880, 2013 | 514 | 2013 |
| Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1 S Rosenkranz, M Flesch, K Amann, C Haeuseler, H Kilter, U Seeland, ... American Journal of Physiology-Heart and Circulatory Physiology 283 (3 …, 2002 | 443 | 2002 |
| Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension … KM Olsson, M Delcroix, HA Ghofrani, H Tiede, D Huscher, R Speich, ... Circulation 129 (1), 57-65, 2014 | 427 | 2014 |
| Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 403 | 2020 |
| Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle H Naito, I Melnychenko, M Didié, K Schneiderbanger, P Schubert, ... Circulation 114 (1_supplement), I-72-I-78, 2006 | 368 | 2006 |
| Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation H ten Freyhaus, M Huntgeburth, K Wingler, J Schnitker, AT Bäumer, ... Cardiovascular research 71 (2), 331-341, 2006 | 314 | 2006 |
| Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum CF Opitz, MM Hoeper, JSR Gibbs, H Kaemmerer, J Pepke-Zaba, ... Journal of the American College of Cardiology 68 (4), 368-378, 2016 | 300 | 2016 |
| Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo … HA Ghofrani, G Simonneau, AM D'Armini, P Fedullo, LS Howard, X Jaïs, ... The Lancet Respiratory Medicine 12 (4), e21-e30, 2024 | 295 | 2024 |
| Pulmonary hypertension MM Hoeper, HA Ghofrani, E Grünig, H Klose, H Olschewski, ... Deutsches Ärzteblatt International 114 (5), 73, 2017 | 288 | 2017 |
| Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thrombosis and haemostasis 120 (07), 1004-1024, 2020 | 287 | 2020 |
| Safety and efficacy of exercise training in various forms of pulmonary hypertension E Grünig, M Lichtblau, N Ehlken, HA Ghofrani, F Reichenberger, ... European Respiratory Journal 40 (1), 84-92, 2012 | 282 | 2012 |
